Kura Oncology, Inc.

KURA ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet › Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2025

Total Assets: $738.4M

Liabilities Breakdown FY2025

Total Liabilities: $564.2M